InformedDNA is the authority on the appropriate use of genetic testing. We leverage the expertise of the largest full-time staff of lab-independent, board-certified genetics specialists to help ensure that health plans, hospitals, employers, community clinicians and patients all have access to the highest quality genetic services. InformedDNA's key offerings include clinical genetic counseling, genetic testing utilization management and payment integrity, and support for clinical trials. For more information, visit InformedDNA.com.
InformedDNA's Mission
Empowering personalized healthcare through expert genomics health information.
For Health Plans:
As the authority on the appropriate use of genetic testing, we can help you promote consistent, evidence-based testing for your members while improving your bottom line. Our program addresses all elements of genetic testing management, from policy development through prior authorization, counseling, lab network optimization, payment integrity, and expert consulting. So, you can unlock significant savings potential without sacrificing quality of care.
For Health Systems:
We employ the nation’s largest, most experienced, full-time genetic counselor staff. Gain access to our network of experts who cover all medical specialties – without the conflicting interests of lab-sponsored counseling. Earn and maintain Commission on Cancer (CoC) accreditation while addressing genetic counseling staffing shortages or temporary staffing needs. Or, get genetic test decision support with our utilization management services.
Life Sciences
We offer proven expertise applying genetics to clinical trials, clinical research programs and natural history studies. Turn to our experts for design and implementation of genetic testing programs, patient identification, genetic counseling, patient & physician engagement, and data collection, analysis and utilization.
InformedDNA's Mission
Empowering personalized healthcare through expert genomics health information.
For Health Plans:
As the authority on the appropriate use of genetic testing, we can help you promote consistent, evidence-based testing for your members while improving your bottom line. Our program addresses all elements of genetic testing management, from policy development through prior authorization, counseling, lab network optimization, payment integrity, and expert consulting. So, you can unlock significant savings potential without sacrificing quality of care.
For Health Systems:
We employ the nation’s largest, most experienced, full-time genetic counselor staff. Gain access to our network of experts who cover all medical specialties – without the conflicting interests of lab-sponsored counseling. Earn and maintain Commission on Cancer (CoC) accreditation while addressing genetic counseling staffing shortages or temporary staffing needs. Or, get genetic test decision support with our utilization management services.
Life Sciences
We offer proven expertise applying genetics to clinical trials, clinical research programs and natural history studies. Turn to our experts for design and implementation of genetic testing programs, patient identification, genetic counseling, patient & physician engagement, and data collection, analysis and utilization.
Location: United States, Florida, Saint Petersburg
Employees: 51-200
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | CIBC Innov... | innovation... |
| - | NovaQuest ... | novaquest.... |
Mentions in press and media 8
| Date | Title | Description |
| 15.05.2024 | Foundation Fighting Blindness Partners with PreventionGenetics and InformedDNA to Advance My Retina Tracker® Genetic Testing Program | Empowering Healthcare Providers and Patients with Genetic Testing and Genetic Counseling Solutions COLUMBIA, Md., May 15, 2024 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and ... |
| 10.01.2024 | Reducing Genetic Testing Barriers for the Charcot-Marie-Tooth Community | Hereditary Neuropathy Foundation Partners with InformedDNA® on CMT Genie Project NEW YORK, NEW YORK , UNITED STATES , January 10, 2024 /EINPresswire.com/ -- In partnership with InformedDNA® , the Hereditary Neuropathy Foundation (HNF) has a... |
| 25.09.2023 | InformedDNA Acquires gWell Health | gWell’s founder and CEO Surya Singh, MD, has transitioned to the role of InformedDNA Chief Executive Officer. (Photo: Business Wire InformedDNA, a St. Petersburg, FL-based company that’s innovating the application of genomic insights, acqui... |
| 09.07.2022 | Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare | Sobha Pisharody, Ph.D., Chief Strategy & Product Officer, InformedDNA Pharmacogenomics—the study of genetic influences on an individual’s response to therapeutic medications—is an area of personalized medicine that is gaining momentum. ... |
| 27.02.2020 | CIBC Innovation Banking Provides InformedDNA With US$10 Million Growth Financing | ST. PETERSBURG, Fla. & MENLO PARK, Calif.–(BUSINESS WIRE)–February 27, 2020– CIBC Innovation Banking is pleased to announce a US$10 million growth capital financing for InformedDNA. Founded in 2005, InformedDNA was built with the vision... |
| 09.01.2020 | InformedDNA Receives Growth Investment | InformedDNA, a St Petersburg, Florida-based provider of genetics services, received a growth investment of undisclosed amount. NovaQuest Capital Management, L.L.C., a healthcare and life sciences focused private investment firm, partnered w... |
| 20.11.2014 | InfoBionic attracts new investors for remote patient monitoring device for chronic conditions | Some of the cool technology bits includes a way for doctors to remotely adjust settings to reduce office visits. A “multipass” analysis tool helps eliminate false positives. Although it transmits a continuous signal of the patient’s heart r... |
| - | InfoBionic attracts new investors for remote patient monitoring device for chronic conditions | InfoBionic, a company that helps doctors identify arrhythmias through its remote monitoring device, Mome Kardia, has raised the second tranche of a $17 million Series B round to commercialize the device following the initial fundraise in Ap... |